In cancer, normal regulatory mechanisms of enzymatic reactions can become dysregulated. For instance, enzymes involved in the cell cycle, such as cyclin-dependent kinases (CDKs), may become overactive, leading to uncontrolled cell proliferation. Additionally, enzymes like matrix metalloproteinases (MMPs) can degrade extracellular matrix components, facilitating tumor invasion and metastasis.
